The Pharmaceutical Journal
Vol 277 No 7407 p7
1 July 2006

This article
Reprint   Photocopy

  Acrobat Reader

Continue to use caution when prescribing naproxen

Naproxen should continue to be prescribed with the same caution as for other non-steroidal anti-inflammatory drugs for patients with cardiovascular risk factors or disease, a MeReC Rapid Review published online last week concludes.

The review considers a BMJ paper (2006;332:1302) which suggested that naproxen may confer less cardiovascular risk than other NSAIDs (PJ, 10 June, p674). MeReC concludes that, until this suggestion is backed up by further evidence, naproxen should continue to be prescribed with the same precautions as other NSAIDs.